NK cell levels predict disease activity in patients with Multiple Sclerosis on Ocrelizumab/Rituximab therapy

被引：0
|
作者：
Dal Bello, Simone [1 ]
Lorenzut, Simone [2 ]
Saccomano, Emma [3 ]
Tereshko, Yan [1 ]
Cargnelutti, Daniela [2 ]
Cutuli, Daniela [2 ]
Gigli, Gian Luigi [3 ]
Valente, Mariarosaria [1 ,3 ]
机构：
[1] Hosp Santa Maria Misericordia, Clin Neurol, Udine, Italy
[2] Hosp Santa Maria Misericordia, Neurol, Udine, Italy
[3] Univ Udine, Dipartiment Med, Dipartimento Area Med, Univ Fruil, Udine, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1483/2062
引用
收藏
页码：944 / 945
页数：2
相关论文
共 50 条
  • [41] Rescue therapy with rituximab in multiple sclerosis
    Sempere, A. P.
    Berenguer-Ruiz, L.
    Gabaldon-Torres, L.
    Tahoces, M. L.
    Sanchez-Perez, R.
    Martin-Medina, P.
    Mendez-Miralles, M. A.
    Volar, L.
    Leiva, C.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 509 - 509
  • [42] Characteristics of NK cell activity in patients with systemic sclerosis
    Salim, Patricia Hartstein
    Jobim, Mariana
    Bredemeier, Markus
    Bogo Chies, Jose Artur
    Tavares Brenol, Joao Carlos
    Jobim, Luiz Fernando
    Xavier, Ricardo Machado
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2013, 53 (01) : 66 - 74
  • [43] A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis
    Iaffaldano, Pietro
    Lucisano, Giuseppe
    Guerra, Tommaso
    Paolicelli, Damiano
    Portaccio, Emilio
    Inglese, Matilde
    Foschi, Matteo
    Patti, Francesco
    Granella, Franco
    Romano, Silvia
    Cavalla, Paola
    De Luca, Giovanna
    Gallo, Paolo
    Bellantonio, Paolo
    Gallo, Antonio
    Montepietra, Sara
    Di Sapio, Alessia
    Vianello, Marika
    Quatrale, Rocco
    Spitaleri, Daniele
    Clerici, Raffaella
    Clerici, Valentina Torri
    Cocco, Eleonora
    Morra, Vincenzo Brescia
    Marfia, Girolama Alessandra
    Boccia, Vincenzo Daniele
    Filippi, Massimo
    Amato, Maria Pia
    Trojano, Maria
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (08): : 2008 - 2015
  • [44] Can we predict ocrelizumab super responder status in relapsing remitting multiple sclerosis patients?
    Edgar, N.
    Hoyt, T.
    Foley, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 267 - 267
  • [45] Ocrelizumab for Post-Alemtuzumab Paradoxical Disease Activity in Highly Active Multiple Sclerosis
    Adamec, Ivan
    Habek, Mario
    CLINICAL NEUROPHARMACOLOGY, 2022, 45 (05) : 139 - 141
  • [46] Longer-term Safety of B-Cell Therapy With Ocrelizumab in Multiple Sclerosis
    Yeh, E. Ann
    Bourdette, Dennis
    Wiendl, Heinz
    NEUROLOGY, 2021, 97 (16) : 751 - 753
  • [47] No Evidence of Disease Activity in the Majority of Pediatric-Onset Multiple Sclerosis Patients Receiving Rituximab
    Shukla, Nikita M.
    Lotze, Timothy
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 40 - 40
  • [48] Switching from natalizumab to ocrelizumab in patients with multiple sclerosis
    Levin, Seth N.
    Ezuma, Chimere
    Levine, Libby
    Vargas, Wendy S.
    Farber, Rebecca S.
    De Jager, Philip L.
    Riley, Claire S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (14) : 1964 - 1965
  • [49] Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study
    Miele, Giuseppina
    Abbadessa, Gianmarco
    Cavalla, Paola
    Valentino, Paola
    Marfia, Girolama Alessandra
    Landi, Doriana
    Bosa, Chiara
    Vercellino, Marco
    De Martino, Antonio
    Ponzano, Marta
    Lavorgna, Luigi
    Bonavita, Simona
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [50] Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study
    Miele, Giuseppina
    Abbadessa, Gianmarco
    Cavalla, Paola
    Valentino, Paola
    Marfia, Girolama Alessandra
    Landi, Doriana
    Bosa, Chiara
    Vercellino, Marco
    De Martino, Antonio
    Ponzano, Marta
    Lavorgna, Luigi
    Bonavita, Simona
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
12345